Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics

Drug Development Research
David Gurwitz

Abstract

At the time of writing this commentary (February 2020), the coronavirus COVID-19 epidemic has already resulted in more fatalities compared with the SARS and MERS coronavirus epidemics combined. Therapeutics that may assist to contain its rapid spread and reduce its high mortality rates are urgently needed. Developing vaccines against the SARS-CoV-2 virus may take many months. Moreover, vaccines based on viral-encoded peptides may not be effective against future coronavirus epidemics, as virus mutations could make them futile. Indeed, new Influenza virus strains emerge every year, requiring new immunizations. A tentative suggestion based on existing therapeutics, which would likely be resistant to new coronavirus mutations, is to use available angiotensin receptor 1 (AT1R) blockers, such as losartan, as therapeutics for reducing the aggressiveness and mortality from SARS-CoV-2 virus infections. This idea is based on observations that the angiotensin-converting enzyme 2 (ACE2) very likely serves as the binding site for SARS-CoV-2, the strain implicated in the current COVID-19 epidemic, similarly to strain SARS-CoV implicated in the 2002-2003 SARS epidemic. This commentary elaborates on the idea of considering AT1R blockers as ten...Continue Reading

References

Jun 28, 2003·Proceedings of the National Academy of Sciences of the United States of America·Robson A S SantosThomas Walther
Dec 17, 2003·Cell·Dimiter S Dimitrov
Jan 13, 2004·Biochemical and Biophysical Research Communications·Ponraj PrabakaranDimiter S Dimitrov
May 29, 2004·Trends in Pharmacological Sciences·Anthony J TurnerNigel M Hooper
Oct 20, 2004·Hypertension·Matthew J HuentelmanDavid A Ostrov
Jul 8, 2005·Nature·Yumiko ImaiJosef M Penninger
Feb 8, 2006·Postgraduate Medical Journal·C-M YuJ J-Y Sung
Jun 1, 2010·Expert Opinion on Drug Metabolism & Toxicology·Sylvia DeppeRalf A Benndorf
Jun 28, 2016·Nature Reviews. Microbiology·Emmie de WitVincent J Munster
Jun 1, 2017·Expert Review of Vaccines·Edward A BelongiaGaston De Serres
Feb 7, 2020·MMWR. Morbidity and Mortality Weekly Report·Anita PatelUNKNOWN 2019-nCoV CDC Response Team
Feb 14, 2020·Journal of Medical Virology·Lei Zhang, Yunhui Liu
Feb 20, 2020·Infection·Zhangkai J Cheng, Jing Shan
Feb 23, 2020·Biochemical and Biophysical Research Communications·Yun ChenZhizhuang Joe Zhao
Mar 5, 2020·Nature Reviews. Drug Discovery·Guangdi Li, Erik De Clercq
Mar 15, 2020·International Journal of Surgery·Syed Ghulam Sarwar Shah, Alexandra Farrow

❮ Previous
Next ❯

Citations

Mar 19, 2020·International Journal of Clinical Practice·George Thomson
Apr 7, 2020·American Journal of Hypertension·Ernesto L SchiffrinR Clinton Webb
Apr 11, 2020·Journal of Biomolecular Structure & Dynamics·Anwarul HasanMojtaba Falahati
Apr 29, 2020·Journal of Primary Care & Community Health·Zach Sartor, Burritt Hess
Apr 30, 2020·Journal of Internal Medicine·Giuseppe PascarellaFelice Eugenio Agrò
Apr 9, 2020·Archives of Toxicology·Joost BoeckmansVera Rogiers
Mar 28, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Thomas C HanffAmir M Mohareb
Mar 10, 2020·Minerva cardioangiologica·Giuseppe Biondi-ZoccaiGiacomo Frati
May 21, 2020·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Spoorthy KulkarniIan Wilkinson
Jun 2, 2020·Hypertension·Paolo VerdecchiaFabio Angeli
May 10, 2020·International Journal of Clinical Pharmacy·Alessio Provenzani, Piera Polidori
Jun 4, 2020·Clinics·Ana Cristina Breithaupt-FaloppaLuiz Felipe Pinho Moreira
Jun 23, 2020·Future Medicinal Chemistry·Siddhi JoshiMariam S Degani
Jun 26, 2020·The Medical Journal of Australia·Emma S ScottGregory R Fulcher
Jun 17, 2020·The Journal of Dermatological Treatment·Mohammad Shahidi-DadrasSahar Dadkhahfar
Jun 20, 2020·Dermatologic Therapy·Suruchi GargRitesh Agarwal
May 7, 2020·Journal of Medical Virology·Lorenzo A CalòLuca Sgarabotto
May 30, 2020·International Journal of Molecular Medicine·George Mihai NitulescuAristidis Tsatsakis
Jun 27, 2020·Diabetes/metabolism Research and Reviews·Yue ZhouYangang Wang
Jul 31, 2020·Molecular Systems Biology·Sanju SinhaEytan Ruppin
Jul 17, 2020·Expert Review of Cardiovascular Therapy·Valentina CaponeCiro Santoro
Aug 5, 2020·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Vincenzo M MondaSandro Gentile
Jul 23, 2020·British Journal of Pharmacology·Claudia PennaPasquale Pagliaro
Aug 14, 2020·International Journal of Food Sciences and Nutrition·Benedetta BottariErasmo Neviani
Jun 1, 2020·The International Journal of Risk & Safety in Medicine·Lo'ai AlanagrehManar Atoum
Aug 29, 2020·Journal of Cardiovascular Medicine·Silvia FrattiniGian B Danzi
Apr 1, 2020·Drug Development Research·Leonardo CaputoSolomon Habtemariam
Sep 10, 2020·PLoS Pathogens·Lien Anh Ha DoPaul V Licciardi
Sep 11, 2020·Drug Discoveries & Therapeutics·Shweta SinhaRakesh Sehgal
Sep 10, 2020·Journal of Cellular Physiology·Mitrasadat RezaeiRamin Pouriran
Sep 17, 2020·Journal of Endocrinological Investigation·C ForestaA Di Nisio
Sep 17, 2020·The Journal of Clinical Hypertension·Jordana B CohenJulio A Chirinos
Sep 24, 2020·Reviews in Medical Virology·Sakthivel SuganyaMadasamy Parani
Aug 7, 2020·American Journal of Physiology. Lung Cellular and Molecular Physiology·Andrea PorzionatoRaffaele De Caro
Jul 30, 2020·American Journal of Physiology. Lung Cellular and Molecular Physiology·Kielan Darcy McAlindenSukhwinder Singh Sohal
Jun 9, 2020·International Journal of Clinical Practice·Paulo Ricardo Martins-FilhoVictor Santana Santos
Jun 18, 2020·Minerva endocrinologica·Subhankar ChatterjeeSanjay Kalra

❮ Previous
Next ❯

Methods Mentioned

BETA
coronary artery ligation

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.